Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community

de réir Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Vavougios, George D., Kalantzis, Georgios, Gourgoulianis, Konstantinos I.
Foilsithe / Cruthaithe 2021

Understanding COVID-19 Epidemiology and Implications for Control: The Experience from a Greek Semi-Closed Community

de réir Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Perlepe, Garyfallia, Miziou, Angeliki, Siachpazidou, Dimitra S., Gourgoulianis, Konstantinos I.
Foilsithe / Cruthaithe 2021

Lessons We Have Learned Regarding Seroprevalence in High and Low SARS-CoV-2 Contexts in Greece before the Omicron Pandemic Wave

de réir Kotsiou, Ourania S., Vavougios, George D., Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Kalampokas, Serafim, Kalantzis, Georgios, Kotsios, Vaios S., Gourgoulianis, Konstantinos I.
Foilsithe / Cruthaithe 2022

The Comparative Superiority of SARS-CoV-2 Antibody Response in Different Immunization Scenarios

de réir Kotsiou, Ourania S., Karakousis, Nikolaos, Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Vavougios, George D., Kalantzis, George, Gourgoulianis, Konstantinos I.
Foilsithe / Cruthaithe 2022